Senior Advisor, Clinical Research, DIA at Eli Lilly and Company

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Medical expertise in clinical strategy, execution, and customer scientific interactions
Ability to collaborate with or lead global teams on clinical development strategy, Phase I-IV trials, and non-trial activities
Experience partnering with regulatory affairs for health authority communications (CTP and NDA processes)
Capability to define patient journey, identify evidence gaps, and develop integrated evidence generation plans and medical strategies
Knowledge to support brand commercialization, local business plans, payer partnerships, negotiation strategies, and dossier preparation
Skills in planning and executing medical meetings, real-world studies, data analyses, and publications while ensuring compliance
Ability to build and maintain relationships with external scientific experts, thought leaders, and the medical community

Responsibilities

Provide medical expertise in clinical strategy, execution, and enhancing customer scientific interactions with Eli Lilly
Collaborate with global teams (or lead, for China-led multi-country studies) on clinical development strategy, Phase I-IV trials, and non-trial activities, ensuring high-quality study planning, execution, and reporting of China data
Partner with regulatory affairs in health authority communications for Clinical Trial Permission (CTP) and New Drug Application (NDA) processes
Lead efforts in defining the patient journey, identifying evidence gaps, and developing integrated evidence generation plans and medical strategies while serving as a patient advocate and medical expert
Support brand commercialization and local business plans by contributing to strategic planning for marketed brands
Provide clinical insights for payer partnerships, negotiation strategies, and dossier preparation to demonstrate product value
Strategically plan and execute medical meetings, real-world studies, data analyses, and publications (abstracts, posters, manuscripts) while ensuring compliance
Build and maintain relationships with external scientific experts, thought leaders, and the broader medical community

Skills

Clinical Research

Phase I-IV Trials

Regulatory Affairs

Health Authority Communications

Clinical Trial Permission (CTP)

New Drug Application (NDA)

Evidence Generation

Medical Strategy

Brand Commercialization

Payer Negotiations

Real-World Studies

Data Analyses

Medical Publications

Compliance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free